Early Pregnancy Clinical Trial
Official title:
Study on Early Screening Biomarkers of Gestational Diabetes Mellitus and Its Related Pathogenesis
Verified date | January 2023 |
Source | Women's Hospital School Of Medicine Zhejiang University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Gestational Diabetes Mellitus (GDM) refers to the abnormal glucose metabolism first detected during pregnancy. It is estimated that approximately 7% of pregnant women worldwide and their offspring are affected by GDM. The incidence of GDM in China is as high as 18.9%. A number of studies have shown that GDM complicates 3%-25% of pregnancies and poses serious health and life threats to the mother and child. In fact, due to the lack of physical activity during pregnancy and the decrease of insulin sensitivity compared with non-pregnancy, the optimal time for intervention has long been lost until the diagnosis of GDM in the second trimester. However, it is a pity that no authoritative screening method for GDM in early pregnancy has been established, and the pathogenesis of GDM is still unclear. This study intend to search for biomarkers used for screening of GDM in early pregnancy and explore the pathogenesis of GDM, so as to provide new ideas for prevention measures and treatment targets of GDM.
Status | Active, not recruiting |
Enrollment | 480 |
Est. completion date | December 31, 2023 |
Est. primary completion date | August 22, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 20 Years to 49 Years |
Eligibility | Inclusion Criteria: - Maternal age: 20-49 years - Plan to have routine prenatal examinations and give birth in the research center - Willing to cooperate with the hospital to follow up Exclusion Criteria: - Have diseases that affect metabolic function or even threaten the life of the mother and fetus before pregnancy, such as diabetes, hypertension, heart disease, liver and kidney diseases, thyroid diseases, autoimmune diseases, malignant tumors, AIDS, etc. - Fetus has a known deformity or genetic defects - Incomplete clinical data |
Country | Name | City | State |
---|---|---|---|
China | Danqing Chen | HangZhou | Zhejiang |
Lead Sponsor | Collaborator |
---|---|
Women's Hospital School Of Medicine Zhejiang University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Significantly different metabolites at 8-10 gestational weeks | Metabolomics are used to screen out significant different metabolites. Specific metabolites indicators will be given based on the results of preliminary experiments. The changes of biomarkers are observed at different gestational weeks. | Gestatioanl weeks: 8-10 weeks | |
Primary | Significantly different metabolites at 16-18 gestational weeks | Metabolomics are used to screen out significant different metabolites. Specific metabolites indicators will be given based on the results of preliminary experiments. The changes of biomarkers are observed at different gestational weeks. | Gestatioanl weeks: 16-18 weeks | |
Primary | Significantly different metabolites at 24-26 gestational weeks | Metabolomics are used to screen out significant different metabolites. Specific metabolites indicators will be given based on the results of preliminary experiments. The changes of biomarkers are observed at different gestational weeks. | Gestatioanl weeks: 24-26 weeks | |
Primary | Significantly different metabolites at 32-34 gestational weeks | Metabolomics are used to screen out significant different metabolites. Specific metabolites indicators will be given based on the results of preliminary experiments. The changes of biomarkers are observed at different gestational weeks. | Gestatioanl weeks: 32-34 weeks | |
Primary | Significantly different proteins at 8-10 gestational weeks | Proteomics are used to screen out significant different proteins. Specific proteins indicators will be given based on the results of preliminary experiments. The changes of biomarkers are observed at different gestational weeks. | Gestatioanl weeks: 8-10 weeks | |
Primary | Significantly different proteins at 16-18 gestational weeks | Proteomics are used to screen out significant different proteins. Specific proteins indicators will be given based on the results of preliminary experiments. The changes of biomarkers are observed at different gestational weeks. | Gestatioanl weeks: 16-18 weeks | |
Primary | Significantly different proteins at 24-26 gestational weeks | Proteomics are used to screen out significant different proteins. Specific proteins indicators will be given based on the results of preliminary experiments. The changes of biomarkers are observed at different gestational weeks. | Gestatioanl weeks: 24-26 weeks | |
Primary | Significantly different proteins at 32-34 gestational weeks | Proteomics are used to screen out significant different proteins. Specific proteins indicators will be given based on the results of preliminary experiments. The changes of biomarkers are observed at different gestational weeks. | Gestatioanl weeks: 32-34 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT01639989 -
Doppler Assesment of Blood Flow in the Spiral Arteries
|
N/A | |
Recruiting |
NCT06002412 -
Quality Control of Ultrasound Images During Early Pregnancy Via AI
|
||
Completed |
NCT03258385 -
Vitamin B12 Supplementation to Improve B12 Status and Child Development
|
N/A | |
Completed |
NCT04152278 -
Chlamydia Tracomatis and Other Lower Genital Tract Infections Among Women With Unexplained Early Miscarriage
|
||
Completed |
NCT03161873 -
Cycle and Pregnancy Monitoring With Wearable Sensor Technology (AVA)
|
||
Active, not recruiting |
NCT03440866 -
Comparison of the Effectiveness of Treatment With Mifepristone and Misoprostol at the Same Time Compared to the Administration of Drugs at a 48-hour Interval for Medical Abortion.
|
N/A | |
Completed |
NCT02979834 -
When Will I Feel The First Movements of My Baby?
|
N/A | |
Terminated |
NCT02847910 -
ClinicaI Observation of Induced Abortion With Disposable Tissue Suction Tube
|
N/A | |
Completed |
NCT04371991 -
Kisspeptin Levels in Early Pregnancy
|
||
Recruiting |
NCT04717661 -
A Diagnostic Test Study of Characteristic Sound Waves in Radial Artery of Early Pregnant Women
|
||
Completed |
NCT05484869 -
Very Advanced Maternal Aged Pregnants and Early Adolescent Pregnant Women
|
||
Recruiting |
NCT04738370 -
Assessment of Biomarkers in Pregnancy on Unknown Location and Ectopic Pregnancy
|
||
Completed |
NCT06228118 -
Clinical Trail of the Lay User Study and Method Comparison Study of Human Chorionic Gonadotropin (HCG) Test System
|
||
Completed |
NCT06228131 -
Detection of hCG in Early Pregnancy Clinical Samples
|
||
Active, not recruiting |
NCT04388605 -
Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic
|
||
Completed |
NCT00340782 -
Influence of Social and Environmental Factors on Women's Reproductive Function in a Maya Community of Guatemala
|
N/A |